↓ Skip to main content

Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting risks earlier

Overview of attention for article published in European Journal of Clinical Pharmacology, April 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting risks earlier
Published in
European Journal of Clinical Pharmacology, April 2014
DOI 10.1007/s00228-014-1670-5
Pubmed ID
Authors

Carlos Alves, Francisco Batel Marques, Ana Filipa Macedo

Abstract

The purpose of this study was to evaluate how risk estimates generated from cumulative meta-analysis performs over time for drugs having their benefit/risk ratio re-evaluated due to safety issues and, additionally, assess whether results are consistent with regulatory authorities' conclusions.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 60 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 18%
Student > Master 11 18%
Student > Bachelor 7 12%
Student > Doctoral Student 5 8%
Student > Ph. D. Student 4 7%
Other 11 18%
Unknown 11 18%
Readers by discipline Count As %
Medicine and Dentistry 19 32%
Pharmacology, Toxicology and Pharmaceutical Science 8 13%
Nursing and Health Professions 4 7%
Agricultural and Biological Sciences 3 5%
Immunology and Microbiology 2 3%
Other 11 18%
Unknown 13 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 June 2014.
All research outputs
#15,302,068
of 22,757,541 outputs
Outputs from European Journal of Clinical Pharmacology
#2,044
of 2,556 outputs
Outputs of similar age
#132,642
of 225,534 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#16
of 24 outputs
Altmetric has tracked 22,757,541 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,556 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,534 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.